Co-Diagnostics Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Dwight Egan
Chief executive officer
US$1.3m
Total compensation
CEO salary percentage | 29.7% |
CEO tenure | 11.6yrs |
CEO ownership | 1.2% |
Management average tenure | less than a year |
Board average tenure | 4yrs |
Recent management updates
Recent updates
Here's Why We're Watching Co-Diagnostics' (NASDAQ:CODX) Cash Burn Situation
Jun 14One Co-Diagnostics, Inc. (NASDAQ:CODX) Analyst Just Slashed Their Estimates By A Consequential 14%
May 18A Look At The Intrinsic Value Of Co-Diagnostics, Inc. (NASDAQ:CODX)
Apr 14Co-Diagnostics: Hold Thesis Remains Well Intact
Sep 07Co-Diagnostics stock sinks ~37% after hours on Q2 results miss, hurt by lower volumes
Aug 11Co-Diagnostics spikes on shipments of monkeypox test
Jul 11Estimating The Intrinsic Value Of Co-Diagnostics, Inc. (NASDAQ:CODX)
Jul 06Co-Diagnostics: Well Priced, Long-Term Value Remains Too Distant
Jun 21Co-Diagnostics: Where's Eikon?
Apr 03Co-Diagnostics, Inc. (NASDAQ:CODX) Shares Could Be 29% Below Their Intrinsic Value Estimate
Mar 28Co-Diagnostics: Swinging For The Fences
Jan 24Does Co-Diagnostics (NASDAQ:CODX) Deserve A Spot On Your Watchlist?
Dec 28Why Co-Diagnostics Is A Solid Covid-19 Play
Aug 19Co-Diagnostics, Inc.'s (NASDAQ:CODX) Share Price Boosted 42% But Its Business Prospects Need A Lift Too
Aug 14CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Sep 30 2024 | n/a | n/a | -US$41m |
Jun 30 2024 | n/a | n/a | -US$38m |
Mar 31 2024 | n/a | n/a | -US$39m |
Dec 31 2023 | US$1m | US$375k | -US$35m |
Sep 30 2023 | n/a | n/a | -US$43m |
Jun 30 2023 | n/a | n/a | -US$38m |
Mar 31 2023 | n/a | n/a | -US$32m |
Dec 31 2022 | US$2m | US$366k | -US$14m |
Sep 30 2022 | n/a | n/a | US$15m |
Jun 30 2022 | n/a | n/a | US$28m |
Mar 31 2022 | n/a | n/a | US$40m |
Dec 31 2021 | US$2m | US$350k | US$37m |
Sep 30 2021 | n/a | n/a | US$42m |
Jun 30 2021 | n/a | n/a | US$46m |
Mar 31 2021 | n/a | n/a | US$51m |
Dec 31 2020 | US$1m | US$309k | US$42m |
Sep 30 2020 | n/a | n/a | US$28m |
Jun 30 2020 | n/a | n/a | US$10m |
Mar 31 2020 | n/a | n/a | -US$6m |
Dec 31 2019 | US$460k | US$275k | -US$6m |
Sep 30 2019 | n/a | n/a | -US$6m |
Jun 30 2019 | n/a | n/a | -US$6m |
Mar 31 2019 | n/a | n/a | -US$6m |
Dec 31 2018 | US$474k | US$275k | -US$6m |
Sep 30 2018 | n/a | n/a | -US$6m |
Jun 30 2018 | n/a | n/a | -US$8m |
Mar 31 2018 | n/a | n/a | -US$8m |
Dec 31 2017 | US$210k | US$195k | -US$7m |
Compensation vs Market: Dwight's total compensation ($USD1.26M) is above average for companies of similar size in the US market ($USD652.28K).
Compensation vs Earnings: Dwight's compensation has been consistent with company performance over the past year.
CEO
Dwight Egan (71 yo)
11.6yrs
Tenure
US$1,261,300
Compensation
Mr. Dwight H. Egan serves as the Chairman & Chief Executive Officer and was President at Co-Diagnostics, Inc. and has been its Director since April 2013. Mr. Egan has been engaged in private investment bus...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chairman & CEO | no data | US$1.26m | 1.15% $ 389.2k | |
CFO & Company Secretary | 3.8yrs | US$1.04m | 0.91% $ 308.1k | |
President | less than a year | no data | 1.85% $ 626.3k | |
Co-Founder & Member of Scientific Advisory Board | 11.6yrs | US$237.50k | no data | |
Chief Operating Officer | less than a year | no data | no data | |
Vice President of Finance & Accounting | no data | no data | no data | |
Chief Technology Officer | less than a year | no data | no data | |
Head of Investor Relations | no data | no data | no data | |
Senior Vice President of Overseas Operations & Strategic Alliances | no data | no data | no data | |
Head of Commercialization LATAM/EUR | no data | no data | no data | |
Chief Regulatory Affairs Officer | 1.3yrs | no data | no data | |
Chief Commercialization Officer | less than a year | no data | no data |
0.7yrs
Average Tenure
50yo
Average Age
Experienced Management: CODX's management team is not considered experienced ( 0.7 years average tenure), which suggests a new team.
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chairman & CEO | 11.6yrs | US$1.26m | 1.15% $ 389.2k | |
Co-Founder & Member of Scientific Advisory Board | 2.7yrs | US$237.50k | no data | |
Independent Director | 7.5yrs | US$298.00k | 0.37% $ 124.6k | |
Chairman of Scientific Advisory Board | 2.7yrs | no data | no data | |
Independent Director | 5.3yrs | US$298.00k | 0.36% $ 121.9k | |
Member of Scientific Advisory Board | 2.7yrs | no data | no data | |
Independent Director | 5.4yrs | US$298.00k | 0.40% $ 135.1k | |
Independent Director | 5.4yrs | US$298.00k | 0.36% $ 121.9k | |
Member of Scientific Advisory Board | 2.7yrs | no data | no data | |
Member of Scientific Advisory Board | 2.7yrs | no data | no data |
4.0yrs
Average Tenure
59yo
Average Age
Experienced Board: CODX's board of directors are considered experienced (4 years average tenure).